These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 337610)

  • 21. [Detection of antinuclear antibodies and their significance as disease markers].
    Yoshida H; Imafuku Y; Morita EO; Nagai T; Kato Y; Motegi S
    Rinsho Byori; 1994 May; 42(5):455-9. PubMed ID: 8022074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rheumatic disease in childhood. Clinical and pathogenetic notes].
    Vaccaro R; Ramenghi M
    Recenti Prog Med; 1971 Jun; 50(6):538-53. PubMed ID: 4944548
    [No Abstract]   [Full Text] [Related]  

  • 23. [Differentiation of antinuclear antibodies for the improvement of their diagnostic significance].
    Rosenthal M; Stojan B; Müller W
    Dtsch Med Wochenschr; 1976 Mar; 101(10):379-84. PubMed ID: 765086
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis and significance of antinuclear antibodies].
    Zuber M
    Dtsch Med Wochenschr; 1994 Mar; 119(11):392-8. PubMed ID: 8131719
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunologic research in the course of several collagenoses in childhood. Evaluation of results from the diagnostic angle].
    Burgio GR; Vaccaro R
    Schweiz Rundsch Med Prax; 1970 Jan; 59(3):75-9. PubMed ID: 4932445
    [No Abstract]   [Full Text] [Related]  

  • 28. Serological indices in Tanzania. II. Antinuclear factor and malarial indices in populations living at different altitudes.
    Voller A; O'Neill P; Humphrey D
    J Trop Med Hyg; 1972 Jul; 75(7):136-9. PubMed ID: 4558431
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fixation in vivo of antinuclear antibodies].
    Guillet G; Fizet D; Claudy A; Thivolet J
    Nouv Presse Med; 1979 Mar; 8(11):869. PubMed ID: 377217
    [No Abstract]   [Full Text] [Related]  

  • 30. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].
    Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C
    Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305
    [No Abstract]   [Full Text] [Related]  

  • 31. Pemphigus and myasthenia gravis.
    Maize JC; Dobson RL; Provost TT
    Arch Dermatol; 1975 Oct; 111(10):1334-9. PubMed ID: 811176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usefulness of determining antinuclear antibodies in the differential diagnosis of inflammatory systemic connective tissue diseases and other childhood diseases].
    Szymańska-Jagiełło W; Musiej-Nowakowska E; Wagner T
    Pediatr Pol; 1985 Mar; 60(3):226-33. PubMed ID: 3876541
    [No Abstract]   [Full Text] [Related]  

  • 33. [The direct immunofluorescence skin test in systemic lupus erythematosus. Correlation with the clinical stage of the disease, laboratory changes and nephropathy].
    dos Santos RF; Santiago MB; Yoshinari NH; Rodrigues CJ; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(4):197-200. PubMed ID: 3074450
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunofluorescence of apparently healthy skin in rheumatoid arthritis].
    Santiago MS; Fava R; Rodrigues CJ; Yoshinari NH; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(3):161-4. PubMed ID: 3074448
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests].
    Schmidt K; Mueller-Eckhardt C; Becker W
    Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunological studies in onchocerciasis in Cameroon.
    Ngu JL; Blackett K
    Trop Geogr Med; 1976 Jun; 28(2):111-20. PubMed ID: 788262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
    Zitńan D; Cebecauer L
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006
    [No Abstract]   [Full Text] [Related]  

  • 38. Specificity of antinuclear factor testing: what does specific mean?
    Stark D; Stein HB; Boyko W
    Can Med Assoc J; 1980 Sep; 123(6):473-4, 476. PubMed ID: 7002273
    [No Abstract]   [Full Text] [Related]  

  • 39. [Focal mesangioproliferative glomerulonephritis].
    Riabov SI; Klemina IK; Plotkin VIa
    Ter Arkh; 1983; 55(6):14-9. PubMed ID: 6225209
    [No Abstract]   [Full Text] [Related]  

  • 40. Abnormalities in the distribution of serum immunoglobulin concentrations in juvenile rheumatoid arthritis.
    Cassidy JT; Petty RE; Sullivan DB
    J Clin Invest; 1973 Aug; 52(8):1931-6. PubMed ID: 4578296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.